Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2025)

Arrowhead Pharmaceuticals (ARWR) has disclosed Exchange Rate Effect for 5 consecutive years, with $106000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 255.88% year-over-year to $106000.0, compared with a TTM value of -$227000.0 through Dec 2025, down 105.58%, and an annual FY2025 reading of -$401000.0, down 109.55% over the prior year.
  • Exchange Rate Effect was $106000.0 for Q4 2025 at Arrowhead Pharmaceuticals, up from -$24000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $4.3 million in Q3 2024 and bottomed at -$402000.0 in Q1 2025.
  • Average Exchange Rate Effect over 5 years is $218411.8, with a median of -$24000.0 recorded in 2025.
  • Peak annual rise in Exchange Rate Effect hit 5000.0% in 2023, while the deepest fall reached 7500.0% in 2023.
  • Year by year, Exchange Rate Effect stood at -$39000.0 in 2021, then plummeted by 212.82% to -$122000.0 in 2022, then surged by 147.54% to $58000.0 in 2023, then tumbled by 217.24% to -$68000.0 in 2024, then soared by 255.88% to $106000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for ARWR at $106000.0 in Q4 2025, -$24000.0 in Q3 2025, and $93000.0 in Q2 2025.